# GUTS (Fractyl Health, Inc.) - SEC EDGAR Financial Statements

> Fractyl Health, Inc. reported $0 in revenue and a net loss of $74.20M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

- Canonical: https://convexityos.com/fundamentals/GUTS
- Markdown: https://convexityos.com/fundamentals/GUTS.md
- SEC CIK: 0001572616
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:06 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001572616&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $0 | -100.0% YoY |
| Operating Income | FY 2025 | -$81.85M | Operating profit |
| Net Income | FY 2025 | -$74.20M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$5.60 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$90.89M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $31.52M | Total debt: $29.89M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Revenue** | $0 | $93K | $120K |
| Cost of Revenue | $0 | $50K | $77K |
| **Gross Profit** | $0 | $43K | $43K |
| Research & Development | $74.54M | $70.47M | $38.04M |
| Selling, General & Admin | $22.28M | $23.10M | $12.84M |
| Total Operating Expenses | $96.82M | $93.57M | $50.88M |
| **Operating Income** | -$96.82M | -$93.53M | -$50.84M |
| **EBITDA** | -$95.69M | -$92.85M | -$50.55M |
| Interest Income | $1.54M | $4.15M | $1.26M |
| Income Tax Expense | $0 | $0 | $0 |
| **Net Income** | -$141.0M | -$68.69M | -$77.09M |
| Basic EPS | -$1.86 | -$1.62 | -$45.31 |
| **Diluted EPS** | -$1.86 | -$1.62 | -$45.31 |
| Basic Shares Outstanding | 75.8M | 43.5M | 2.1M |
| Diluted Shares Outstanding | 75.8M | 43.5M | 2.1M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | -- | -- | $3.0K |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | -- | $3.0K |
| Research & Development | $12.45M | $13.81M | $15.60M | $16.49M | $17.46M | $21.15M | $19.43M | $20.28M |
| Selling, General & Admin | $6.20M | $5.28M | $5.22M | $6.79M | $5.24M | $4.93M | $5.32M | $4.93M |
| Total Operating Expenses | $18.65M | $19.10M | $20.82M | $23.28M | $22.69M | $26.08M | $24.76M | $25.21M |
| **Operating Income** | -$18.65M | -$19.10M | -$20.82M | -$23.28M | -$22.69M | -$26.08M | -$24.76M | -$25.21M |
| **EBITDA** | -$18.37M | -$18.82M | -$20.54M | -$23.00M | -$22.40M | -$25.81M | -$24.47M | -$24.99M |
| Interest Income | $297K | $431K | $593K | $645K | $166K | $226K | $503K | $726K |
| **Net Income** | -$14.15M | -$25.54M | $9.22M | -$43.73M | -$45.60M | -$27.89M | -$23.73M | -$24.97M |
| Basic EPS | -$1.07 | -$0.16 | $0.06 | -- | -$8.46 | -$0.57 | -$0.49 | -- |
| **Diluted EPS** | -$1.07 | -$0.16 | $0.06 | -- | -$8.46 | -$0.57 | -$0.49 | -- |
| Basic Shares Outstanding | 13.3M | 158.6M | 158.4M | -- | 5.4M | 49.0M | 48.8M | -- |
| Diluted Shares Outstanding | 13.3M | 158.6M | 158.4M | -- | 5.4M | 49.0M | 48.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $81.54M | $67.46M | $33.21M |
| **Cash & Short-Term Investments** | $81.54M | $67.46M | $33.21M |
| Accounts Receivable, Net | -- | $0 | $22K |
| Inventory | -- | $73K | $73K |
| **Total Current Assets** | $87.58M | $71.76M | $35.65M |
| Property, Plant & Equipment, Net | $2.41M | $2.98M | $490K |
| Other Non-Current Assets | $337K | $666K | $5.54M |
| **Total Non-Current Assets** | $33.83M | $36.31M | $40.56M |
| **Total Assets** | $121.4M | $108.1M | $76.21M |
| Accounts Payable | $1.57M | $3.24M | $553K |
| **Total Current Liabilities** | $18.33M | $19.77M | $11.19M |
| Other Non-Current Liabilities | $663K | $998K | -- |
| **Total Non-Current Liabilities** | $93.61M | $59.88M | $102.8M |
| **Total Liabilities** | $111.9M | $79.65M | $113.9M |
| **Total Debt (incl. Leases)** | $31.06M | $32.34M | $31.24M |
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$556.3M | -$415.3M | -$346.6M |
| **Total Stockholders' Equity** | $9.46M | $28.42M | -$325.1M |
| Total Equity | $9.46M | $28.42M | -$325.1M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $31.52M | $47.14M | $63.17M | $81.54M | $77.66M | $22.29M | $42.11M | $67.46M |
| **Cash & Short-Term Investments** | $31.52M | $47.14M | $63.17M | $81.54M | $77.66M | $22.29M | $42.11M | $67.46M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | $0 |
| Inventory | -- | -- | -- | -- | -- | -- | -- | $73K |
| **Total Current Assets** | $34.33M | $49.60M | $65.92M | $87.58M | $79.70M | $26.69M | $47.05M | $71.76M |
| Property, Plant & Equipment, Net | $1.69M | $1.85M | $2.13M | $2.41M | $2.68M | $2.96M | $3.14M | $2.98M |
| Other Non-Current Assets | $132K | $304K | $681K | $337K | $392K | $458K | $571K | $666K |
| **Total Non-Current Assets** | $31.59M | $32.37M | $33.47M | $33.83M | $34.57M | $35.32M | $35.99M | $36.31M |
| **Total Assets** | $65.92M | $81.98M | $99.39M | $121.4M | $114.3M | $62.01M | $83.04M | $108.1M |
| Accounts Payable | $1.73M | $1.01M | $1.65M | $1.57M | $1.26M | $3.91M | $1.48M | $3.24M |
| **Total Current Liabilities** | $17.34M | $15.74M | $15.41M | $18.33M | $18.68M | $21.83M | $18.80M | $19.77M |
| Other Non-Current Liabilities | $555K | $510K | $569K | $663K | $753K | $838K | $920K | $998K |
| **Total Non-Current Liabilities** | $61.80M | $67.91M | $62.60M | $93.61M | $98.77M | $58.39M | $57.86M | $59.88M |
| **Total Liabilities** | $79.14M | $83.64M | $78.01M | $111.9M | $117.5M | $80.22M | $76.67M | $79.65M |
| **Total Debt (incl. Leases)** | $29.89M | $30.29M | $30.68M | $31.06M | $31.41M | $31.73M | $32.04M | $32.34M |
| Common Stock | $0 | $1.0K | $1.0K | $0 | $1.0K | $0 | $0 | $0 |
| Retained Earnings | -$586.7M | -$572.6M | -$547.0M | -$556.3M | -$512.5M | -$466.9M | -$439.0M | -$415.3M |
| **Total Stockholders' Equity** | -$13.22M | -$1.67M | $21.38M | $9.46M | -$3.18M | -$18.21M | $6.38M | $28.42M |
| Total Equity | -$13.22M | -$1.67M | $21.38M | $9.46M | -$3.18M | -$18.21M | $6.38M | $28.42M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | -$141.0M | -$68.69M | -$77.09M |
| Depreciation & Amortization | $1.13M | $677K | $286K |
| Stock-Based Compensation | $6.68M | $14.43M | $4.30M |
| Change in Receivables | -- | $22K | -$22K |
| Change in Inventory | $73K | -- | -$73K |
| Change in Payables | -$1.67M | $2.69M | -$427K |
| **Operating Cash Flow** | -$90.33M | -$65.52M | -$42.82M |
| Capital Expenditure | -$557K | -$1.76M | -$359K |
| **Free Cash Flow** | -$90.89M | -$67.29M | -$43.18M |
| **Investing Cash Flow** | -$557K | -$1.76M | -$359K |
| Common Stock Issued | $6.78M | -- | -- |
| **Financing Cash Flow** | $105.0M | $101.2M | $27.44M |
| **Net Change in Cash** | $14.08M | $33.94M | -$15.74M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$14.15M | -$25.54M | $9.22M | -$43.73M | -$45.60M | -$27.89M | -$23.73M | -$24.97M |
| Depreciation & Amortization | $276K | $278K | $281K | $279K | $290K | $270K | $290K | $223K |
| Stock-Based Compensation | $2.39M | $2.50M | $2.53M | $1.85M | $1.64M | $1.78M | $1.41M | $2.90M |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | $0 |
| Change in Inventory | -- | -- | -- | $0 | $0 | $0 | $73K | -- |
| Change in Payables | $704K | -$643K | $75K | $318K | -$2.65M | $2.43M | -$1.76M | $1.50M |
| **Operating Cash Flow** | -$15.71M | -$15.90M | -$22.48M | -$21.34M | -$22.71M | -$21.20M | -$25.08M | -$17.03M |
| Capital Expenditure | -- | -- | -- | -$3.0K | -$8.0K | -$98K | -$448K | -$233K |
| **Free Cash Flow** | -- | -- | -- | -$21.34M | -$22.72M | -$21.30M | -$25.53M | -$17.27M |
| **Investing Cash Flow** | -- | -- | -- | -$3.0K | -$8.0K | -$98K | -$448K | -$233K |
| Common Stock Issued | -- | -- | $170K | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $83K | -$127K | $4.11M | $25.22M | $78.09M | $1.48M | $171K | $67K |
| **Net Change in Cash** | -$15.62M | -$16.03M | -$18.37M | $3.88M | $55.37M | -$19.82M | -$25.36M | -$17.20M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Gross Margin** | -- | 46.2% | 35.8% |
| **Operating Margin** | -- | -100571.0% | -42363.3% |
| **Net Profit Margin** | -- | -73864.5% | -64242.5% |
| Return on Equity (ROE) | -1490.3% | -241.7% | -- |
| Return on Assets (ROA) | -116.1% | -63.6% | -101.2% |
| Current Ratio | 4.78x | 3.63x | 3.19x |
| Quick Ratio | 4.45x | 3.63x | 3.18x |
| Debt to Equity | 3.28x | 1.14x | -- |
| **Revenue Growth (YoY)** | -100.0% | -22.5% | -- |
| Gross Profit Growth (YoY) | -100.0% | 0.0% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | -- | 46.2% |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -- | -100571.0% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -- | -73864.5% |
| Return on Equity (ROE) | -- | -- | -505.2% | -1490.3% | -- | -- | -1397.8% | -241.7% |
| Return on Assets (ROA) | -112.5% | -128.9% | -108.7% | -116.1% | -106.9% | -160.9% | -107.3% | -63.6% |
| Current Ratio | 1.98x | 3.15x | 4.28x | 4.78x | 4.27x | 1.22x | 2.50x | 3.63x |
| Quick Ratio | 1.82x | 3.00x | 4.10x | 4.45x | 4.16x | 1.02x | 2.24x | 3.63x |
| Debt to Equity | -- | -- | 1.44x | 3.28x | -- | -- | 5.03x | 1.14x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -57.1% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -40.0% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
